Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Cardiovascular Diseases × Genetic Testing × Breast × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 12 Ovarian Neoplasms 2 Neoplasms, Unknown Primary 2 Hereditary Breast and Ovarian Cancer Syndrome 2 Colorectal Neoplasms 2 Brain Neoplasms 2 Women Age 35+ Qualifies if >15% Lifetime Risk of Breast Cancer as Defined by IBIS Version 8 1 Urogenital Neoplasms 1 Primary Ovarian Insufficiency 1 Neoplastic Syndromes, Hereditary 1 Neoplasm Metastasis 1 Hot Flashes 1 Head and Neck Neoplasms 1 HER2-positive Breast Cancer 1 Digestive System Neoplasms 1 Depression 1 Colorectal Neoplasms, Hereditary Nonpolyposis 1 Central Nervous System Neoplasms 1 Cardiovascular Diseases 1 Carcinoma, Intraductal, Noninfiltrating 1 Breast Screening 1 Anatomic Stage II Breast Cancer AJCC v8 1 Anatomic Stage I Breast Cancer AJCC v8 1

Interventions

palbociclib 2 Blood Pressure 2 xinmailong 1 ribociclib 1 abemaciclib 1 Social Determinants of Health 1 Rivaroxaban 1 Restraint, Physical 1 Raloxifene Hydrochloride 1 Quality of Life 1 Progesterone 1 Positron-Emission Tomography 1 Patient Navigation 1 Linseed Oil 1 High-Intensity Interval Training 1 Heart Rate 1 Heart Function Tests 1 Genetic Testing 1 Exercise 1 Estradiol 1 Anthracyclines 1 Absorptiometry, Photon 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02485626 2016-10-31

HARBOR

The Netherlands Cancer Institute

Breast Neoplasms, Cardiovascular Diseases

Data powered by HemOnc (CC BY 4.0) Colophon ⚡